Association between SGLT2 Inhibitors and Risk of Dementia and Parkinson’s Disease: A Meta-Analysis of 12 Randomized Controlled Trials

By sjmartinez • July 9, 2024

Jaiswal V, Mashkoor Y, Raj N, Rajak K, Jaiswal A, Fonarow GC. Association between SGLT2 Inhibitors and Risk of Dementia and Parkinson's Disease: A Meta-Analysis of 12 Randomized Controlled Trials. Am J Med. 2024 Jul 6:S0002-9343(24)00420-0. doi: 10.1016/j.amjmed.2024.06.030. Epub ahead of print. PMID: 38977148.

Tags: Cardiology/Epi, Dementia, diabetes mellitus, heart failure, Parkinson’s disease, Publications, SGLT2I

In-hospital initiation of sodium-glucose co-transporter-2 inhibitors in patients with acute heart failure

Arshad MS, Jamil A, Greene SJ, Van Spall HGC, Fonarow GC, Butler J, Khan MS. In-hospital initiation of sodium-glucose co-transporter-2 inhibitors in patients with acute[...]

Anti-Inflammatory Oxysterol, Oxy210, Inhibits Atherosclerosis in Hyperlipidemic Mice and Inflammatory Responses of Vascular Cells

Stappenbeck F, Wang F, Sinha SK, Hui ST, Farahi L, Mukhamedova N, Fleetwood A, Murphy AJ, Sviridov D, Lusis AJ, Parhami F. Anti-Inflammatory Oxysterol, Oxy210,[...]

Calcified aneurysm in the left anterior descending artery

Bishay R, Krishnan S, Budoff MJ. Calcified aneurysm in the left anterior descending artery. Coron Artery Dis. 2024 Oct 15. doi: 10.1097/MCA.0000000000001436. Epub ahead of[...]